Cargando…
Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract
BACKGROUND: Carcinomas of the renal pelvis and ureter are rare diseases, accounting for only about 1% of all urogenital malignancies. Previous reports suggest that squamous cell histology is associated with inferior survival. We present the largest population based analysis to date of survival in pa...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256977/ https://www.ncbi.nlm.nih.gov/pubmed/22253551 http://dx.doi.org/10.4137/CMO.S8103 |
_version_ | 1782221085874323456 |
---|---|
author | Berz, David Rizack, Tina Weitzen, Sherry Mega, Anthony Renzulli, Joseph Colvin, Gerald |
author_facet | Berz, David Rizack, Tina Weitzen, Sherry Mega, Anthony Renzulli, Joseph Colvin, Gerald |
author_sort | Berz, David |
collection | PubMed |
description | BACKGROUND: Carcinomas of the renal pelvis and ureter are rare diseases, accounting for only about 1% of all urogenital malignancies. Previous reports suggest that squamous cell histology is associated with inferior survival. We present the largest population based analysis to date of survival in patients with upper urinary tract malignancies. METHODS: We analyzed the Surveillance, Epidemiology and End Results database for cancer specific survival rates in patients with renal pelvis and ureteral malignancies who were diagnosed between 1973 and 2003 in the SEER catchment geographic areas. The primary exposure of interest was the underlying histology, squamous cell versus transitional cell differentiation. We performed descriptive statistics, non parametric survival analysis, and cox proportional hazard analysis. RESULTS: We identified 13,213 eligible patients, 7,716 renal pelvis and 5,497 ureteral carcinomas. Among this cohort, 179 patients had squamous cell carcinoma (SCC), 12,395 had transitional cell carcinoma (TCC), including 121 papillary, and 619 had other histologies. Overall, patients with SCC histology fared worse. The median overall survival time was 10 months for SCC and 63 months for TCC. The cox analysis revealed a HR 3.7 (95% CI 3.0–4.5) for SCC when compared to TCC and corrected for decade of diagnosis, age, gender, prior treatment, and race. The difference between the two groups was entirely attributable to survival differences in patients with loco-regional disease. However, when stratified by lymph node involvement this difference disappeared for patients with locally involved lymph nodes (P = 0.84) and for patients with clear lymph nodes (P = 0.92). CONCLUSIONS: SCCs of the upper urinary tract present at a higher clinical stage and appear to represent more aggressive disease when compared to other histologies. However, when appropriately staged according to lymph node status, the survival of TCC and SCC of the upper urinary tract is identical when compared stage by stage. |
format | Online Article Text |
id | pubmed-3256977 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Libertas Academica |
record_format | MEDLINE/PubMed |
spelling | pubmed-32569772012-01-17 Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract Berz, David Rizack, Tina Weitzen, Sherry Mega, Anthony Renzulli, Joseph Colvin, Gerald Clin Med Insights Oncol Original Research BACKGROUND: Carcinomas of the renal pelvis and ureter are rare diseases, accounting for only about 1% of all urogenital malignancies. Previous reports suggest that squamous cell histology is associated with inferior survival. We present the largest population based analysis to date of survival in patients with upper urinary tract malignancies. METHODS: We analyzed the Surveillance, Epidemiology and End Results database for cancer specific survival rates in patients with renal pelvis and ureteral malignancies who were diagnosed between 1973 and 2003 in the SEER catchment geographic areas. The primary exposure of interest was the underlying histology, squamous cell versus transitional cell differentiation. We performed descriptive statistics, non parametric survival analysis, and cox proportional hazard analysis. RESULTS: We identified 13,213 eligible patients, 7,716 renal pelvis and 5,497 ureteral carcinomas. Among this cohort, 179 patients had squamous cell carcinoma (SCC), 12,395 had transitional cell carcinoma (TCC), including 121 papillary, and 619 had other histologies. Overall, patients with SCC histology fared worse. The median overall survival time was 10 months for SCC and 63 months for TCC. The cox analysis revealed a HR 3.7 (95% CI 3.0–4.5) for SCC when compared to TCC and corrected for decade of diagnosis, age, gender, prior treatment, and race. The difference between the two groups was entirely attributable to survival differences in patients with loco-regional disease. However, when stratified by lymph node involvement this difference disappeared for patients with locally involved lymph nodes (P = 0.84) and for patients with clear lymph nodes (P = 0.92). CONCLUSIONS: SCCs of the upper urinary tract present at a higher clinical stage and appear to represent more aggressive disease when compared to other histologies. However, when appropriately staged according to lymph node status, the survival of TCC and SCC of the upper urinary tract is identical when compared stage by stage. Libertas Academica 2011-12-12 /pmc/articles/PMC3256977/ /pubmed/22253551 http://dx.doi.org/10.4137/CMO.S8103 Text en © the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited. |
spellingShingle | Original Research Berz, David Rizack, Tina Weitzen, Sherry Mega, Anthony Renzulli, Joseph Colvin, Gerald Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract |
title | Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract |
title_full | Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract |
title_fullStr | Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract |
title_full_unstemmed | Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract |
title_short | Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract |
title_sort | survival of patients with squamous cell malignancies of the upper urinary tract |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256977/ https://www.ncbi.nlm.nih.gov/pubmed/22253551 http://dx.doi.org/10.4137/CMO.S8103 |
work_keys_str_mv | AT berzdavid survivalofpatientswithsquamouscellmalignanciesoftheupperurinarytract AT rizacktina survivalofpatientswithsquamouscellmalignanciesoftheupperurinarytract AT weitzensherry survivalofpatientswithsquamouscellmalignanciesoftheupperurinarytract AT megaanthony survivalofpatientswithsquamouscellmalignanciesoftheupperurinarytract AT renzullijoseph survivalofpatientswithsquamouscellmalignanciesoftheupperurinarytract AT colvingerald survivalofpatientswithsquamouscellmalignanciesoftheupperurinarytract |